Long-term treatment of chronic migraine with OnabotulinumtoxinA: Efficacy, 
quality of life and tolerability in a real-life setting

Kollewe, Katja; Escher, Claus M.; Wulff, Dirk U.; Fathi, Davood; Paracka, Lejla; Mohammadi, Bahram; Karst, Matthias; Dressler, Dirk

doi:10.1007/s00702-016-1539-0

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

Long-term treatment of chronic migraine with OnabotulinumtoxinA: Efficacy, quality of life and tolerability in a real-life setting

MPS-Authors

/persons/resource/persons139851

Wulff, Dirk U.
Center for Adaptive Rationality, Max Planck Institute for Human Development, Max Planck Society;

External Resource

http://dx.doi.org/10.1007/s00702-016-1539-0
(Publisher version)

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Kollewe, K., Escher, C. M., Wulff, D. U., Fathi, D., Paracka, L., Mohammadi, B., et al. (2016). Long-term treatment of chronic migraine with OnabotulinumtoxinA: Efficacy, quality of life and tolerability in a real-life setting. Journal of Neural Transmission, 123(5), 533-540. doi:10.1007/s00702-016-1539-0.

Cite as: https://hdl.handle.net/11858/00-001M-0000-002A-5A9C-C

Abstract

There is no abstract available